The Latest "Buzz on the Street" Show: Featuring Pasha Brands (CSE: CRFT) (OTC: CRFTF) Acquires Baked Edibles | Financial Buzz

The Latest “Buzz on the Street” Show: Featuring Pasha Brands (CSE: CRFT) (OTC: CRFTF) Acquires Baked Edibles

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Pasha Brands Acquires Iconic Brand Baked Edibles.”

Pasha Brands Ltd. (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD), Canada’s largest craft cannabis brands organization, has announced it has acquired the brand “Baked Edibles” (“Baked Edibles”), previously used by Canada’s longest-running commercial cannabis bakery. In its previous iteration, Baked Edibles was an iconic pre-legalization brand that served Canadians for years and will now take its place among leading edible brands in the regulated market.

Based in Vancouver, British Columbia, Pasha Brands is a vertically integrated organization that is firmly rooted in BC’s craft cannabis industry, which boasts an international reputation. With proven capabilities in cannabis cultivation, genetic research and development, product, processing, and retail, Pasha is uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers under the Pasha umbrella.

Pasha’s subsidiary, BC Craft Supply Co. Ltd., is developing a craft cannabis campus, which is dedicated to bringing craft quality into the newly legal cannabis market in Canada. BC Craft Supply Co. Ltd. is driven to assist craft growers in obtaining security clearance and licensing to grow as micro-cultivators, specializing in education and compliance to bring growers into the regulated cannabis supply market.

The burden of dealing with symptoms associated with medical conditions has financially and physically ravaged millions of people around the globe. Every day, people suffering from medical conditions are distraught by the harsh effects of the symptoms derived from their ailments. For instance, patients receiving cancer therapy can face a plethora of side effects such as nausea and severe pain. Generally, patients take a plethora of medicines in order to subdue these side effects, and in particular, cancer patients suffering from chronic pain may be prescribed dangerous opioids from their physician. As a result, more medical institutions are beginning to recommend cannabis as an alternative to treat the adverse conditions associated with cancer. The American Cancer Society has even cited studies that determined that marijuana can be helpful in treating the side effects of cancer chemotherapy. A few studies have even uncovered that inhaled (smoked or vaporized) marijuana can help with the treatment of neuropathic pain. And more recently, scientists have also reported that THC and other cannabinoids such as CBD can slow the growth of and possibly even eliminate cancer cells, ultimately reducing the spread of certain forms of cancer. Other studies have also suggested that cannabinoids can be safe for humans in treating cancer, which has led to the widespread use of medical cannabis around the world. Now, as more global government agencies collect positive data from clinical trials, additional nations will move towards legalizing medical cannabis because of its potentially valuable therapeutic effects. And as a result, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025 while registering a CAGR of 34.6%, according to data compiled by Grand View Research. 

A multitude of studies have so far confirmed that cannabis has effectively helped patients deal with their medical conditions compared to their previous medications. For instance, the National Academies of Sciences, Engineering, and Medicine (NASEM) released a study in 2017 which uncovered that chronic pain patients treated with medical cannabis reported a significant reduction in pain symptoms. However, patients using medical cannabis for chronic pain are typically required to consume it every day. In some severe cases, patients have reported that they cannot go a single day without consuming cannabis because their pain is not tolerable. However, the major drawback is that patients can easily develop a tolerance for the plant’s effects. And once a patient’s tolerance levels get too high, he or she will need to consume even more cannabis, which can, in turn, become expensive. As such, many patients have shifted from dried cannabis flower to extracts and concentrates because they are much more potent and deliver the effects almost immediately when compared to flower. Despite the shift, there is still a large demand for dried cannabis flower because it is used to create these highly-potent cannabis-based products. Furthermore, the quality of dried cannabis can determine the potency of other products, which is why premium quality is being demanded. For example, “craft cannabis” producers have become increasingly popular because of their high-quality cannabis buds. Additionally, consumers are beginning to opt towards strains from craft producers because large-scale licensed producers sometimes lack sufficient quality. Overall, craft cannabis is similar to craft beer where producers are passionate about their product and typically, craft cannabis producers take extensive measures to ensure top-shelf quality by meticulously monitoring each plant and hand-trimming the buds. Ultimately, craft producers create natural and potent products that are enjoyed by both recreational and medical cannabis users. “The art of cannabis has come a long way from the days of the dime bag, when you had no idea where your cannabis came from, what kind of pesticides or growing methods produced it, or even what strain it was. These days, in the legal cannabis marketplace, you have your choice of the best of the best of ‘craft cannabis,'” said Lisa Rough, former Associate Editor at Leafly. 

For more information, please visit: Pasha Brands Ltd.

For more corporate news on Pasha Brands Ltd., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Sponsored Content Release. Click for Full Disclosure

2 Comments
  1. Pasi Milak 2 months ago
    Reply

    I much prefer edibles versus natural flower and oils as I hate putting pressure on my lungs

  2. Bruce Tennen 2 months ago
    Reply

    Did you know that Cannabis Edibles accounted for 11% or $54M of sales across WA, CO, NV and CA?
    Furthermore, edibles experience sales seasonality (down in April, up in December)

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For pasha brands ltd. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.